h.mensah
TL2 Moderator · Valencia
Contributes reviews on supplier material. Based in Valencia.
Joined 2 December 2024 · last posted 4d
76 posts, newest first. Showing up to 150.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #94 · Practice › Dosing & titration · 24 Jul 2026 · 13 likes post #93 is right about the mechanism and I think understates the practical bit. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #14 · Compounds › Tirzepatide · 22 Jul 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Which categories are strict and which are relaxed, honestly Replied, post #23 · Start Here › Welcome · 17 Jul 2026 · 8 likes Coming back to post #21, because the follow-up matters more than the original answer. Marked solutions are the site's way of saying that someone asked a good question…
-
Common supplements people ask about, assessed one at a time Replied, post #53 · Practice › Interactions · 16 Jul 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #31 · Access › Insurance & coverage · 15 Jul 2026 · 10 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #81 · Analytics › Home & field testing · 13 Jul 2026 · 2 likes I read post #79 twice before replying, because I had assumed the opposite. What physical quantity does the device measure? A colorimetric or lateral-flow method…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #16 · Practice › Interactions · 11 Jul 2026 · 19 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #9 · Research Methods › N-of-1 designs · 10 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #37 · Evidence › Journal club · 8 Jul 2026 · 30 likes On post #33 — agreed on the reasoning, with one qualification. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose…
-
Tracking a shortage from primary sources rather than rumour Replied, post #83 · Access › Shortages · 3 Jul 2026 · 20 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #14 · Analytics › Mass spectrometry · 29 Jun 2026 · 0 likes Picking up post #11: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Insurance and replacement policies, compared Replied, post #50 · Sourcing › Logistics · 29 Jun 2026 · 14 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #114 · Practice › Storage & stability · 9 Jun 2026 · 7 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #2 · Evidence › Journal club · 25 May 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #27 · Practice › Storage & stability · 14 May 2026 · 8 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Follow-up: Sleep quality changes during weight loss Replied, post #12 · Wellbeing › Sleep · 28 Apr 2026 · 10 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #119 · Practice › Reconstitution · 25 Apr 2026 · 2 likes Coming back to post #117, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #49 · Practice › Administration · 24 Apr 2026 · 18 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
How to ask about something you suspect is a bad idea Replied, post #79 · Start Here › How to Ask · 21 Apr 2026 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: State-level differences that actually matter Replied, post #84 · Regional › North America · 8 Apr 2026 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Choosing which test to pay for, given a fixed budget Replied, post #47 · Sourcing › Independent verification · 31 Mar 2026 · 27 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
A site rotation scheme that is easy enough to actually follow Replied, post #25 · Practice › Administration · 22 Mar 2026 · 4 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Grapefruit: why this class is not the class that cares Replied, post #44 · Practice › Interactions · 15 Mar 2026 · 23 likes post #43 is right about the mechanism and I think understates the practical bit. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #119 · Practice › Interactions · 25 Feb 2026 · 13 likes Picking up post #116: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #93 · Access › Pricing · 18 Feb 2026 · 8 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #53 · Outcomes › Progress reports · 14 Feb 2026 · 0 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
MHRA statements, read directly Replied, post #87 · Regional › UK & Ireland · 12 Feb 2026 · 2 likes On post #83 — agreed on the reasoning, with one qualification. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful.…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #84 · Wellbeing › Mental health · 30 Jan 2026 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #65 · Clinical › Special populations · 1 Jan 2026 · 4 likes I read post #63 twice before replying, because I had assumed the opposite. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #77 · Practice › Interactions · 27 Dec 2025 · 1 like Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #15 · Access › International · 17 Dec 2025 · 9 likes I read post #13 twice before replying, because I had assumed the opposite. Currency and exchange rates: paying in different currencies has different costs and risks.…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #44 · Compounds › Semaglutide · 13 Dec 2025 · 6 likes This follows post #41 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Tracking a preprint to publication: a worked example Replied, post #49 · Evidence › Preprints · 4 Dec 2025 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #28 · Data & Tools › Calculators · 4 Dec 2025 · 8 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #3 · Analytics › COA interpretation · 28 Nov 2025 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Amylin receptor signalling and satiety Replied, post #27 · Pharmacology › Receptor biology · 3 Nov 2025 · 4 likes I read post #25 twice before replying, because I had assumed the opposite. Bias and desensitisation: receptors can be biased (preferentially activating some downstream…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #41 · Analytics › Home & field testing · 29 Oct 2025 · 0 likes Picking up post #38: that is the part I would want checked first. What physical quantity does the device measure? A colorimetric or lateral-flow method typically…
-
Publishing an inconvenient result: a case study — the long version Replied, post #7 · Sourcing › Independent verification · 11 Oct 2025 · 23 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #141 · Data & Tools › Calculators · 6 Oct 2025 · 20 likes Picking up post #138: that is the part I would want checked first. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #39 · Pharmacology › Receptor biology · 13 Sep 2025 · 29 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #102 · Access › Insurance & coverage · 1 Sep 2025 · 4 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #12 · Sourcing › Regulatory · 24 Aug 2025 · 10 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Asking about a compound your prescriber has not heard of Replied, post #113 · Clinical › Prescriber conversations · 2 Aug 2025 · 10 likes On post #109 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
-
Research-use-only labelling: what it means and what it does not Replied, post #10 · Sourcing › Regulatory · 9 Jul 2025 · 9 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #81 · Practice › Storage & stability · 7 Jul 2025 · 9 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Repeatability versus intermediate precision Replied, post #119 · Analytics › Method validation · 2 Jul 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What I would record differently if I started again — the long version Replied, post #2 · Outcomes › Progress reports · 12 Jun 2025 · 9 likes the opening post answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #71 · Access › Insurance & coverage · 11 Jun 2025 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #50 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #26 · Evidence › Journal club · 4 Jun 2025 · 0 likes This follows post #23 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Half-life, steady state, and accumulation worked through Replied, post #48 · Pharmacology › Pharmacokinetics · 31 May 2025 · 5 likes post #47 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Pregnancy as an absolute contraindication Replied, post #95 · Safety › Contraindications · 20 May 2025 · 21 likes This follows post #92 rather than contradicting it. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #52 · Sourcing › Independent verification · 5 May 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Follow-up: Documentation that appears only after payment Replied, post #21 · Sourcing › Red flags · 25 Apr 2025 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #97 · Evidence › Journal club · 21 Apr 2025 · 4 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Units, standards, and other things that quietly hold the world together Replied, post #17 · Lounge › Off topic · 11 Apr 2025 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #3 · Analytics › Method validation · 9 Apr 2025 · 23 likes Coming back to the opening post, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the…
-
Follow-up: What other technical communities get right that we do not Replied, post #61 · Lounge › Off topic · 7 Apr 2025 · 7 likes On post #57 — agreed on the reasoning, with one qualification. Community norms: if you want to discuss how the community should work (not moderation decisions, which go…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #45 · Practice › Reconstitution · 6 Apr 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Charge states for a 4 kDa peptide, worked through Replied, post #129 · Analytics › Mass spectrometry · 17 Mar 2025 · 5 likes On post #125 — agreed on the reasoning, with one qualification. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #102 · Access › International · 16 Mar 2025 · 5 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #37 · Compounds › Semaglutide · 12 Mar 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Validating a method you did not develop — does this still hold? Replied, post #41 · Analytics › Method validation · 24 Feb 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
SNAC and the mechanism of oral peptide absorption Replied, post #12 · Compounds › Oral incretins · 23 Feb 2025 · 30 likes post #11 is right about the mechanism and I think understates the practical bit. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #24 · Practice › Reconstitution · 1 Feb 2025 · 28 likes I read post #22 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #6 · Practice › Dosing & titration · 28 Jan 2025 · 3 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #94 · Compounds › Tirzepatide · 17 Dec 2024 · 5 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #2 · Compounds › Semaglutide · 17 Dec 2024 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 9 Dec 2024 · 1 like What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
EMA product information as a primary source — does this still hold? Replied, post #14 · Regional › European Union · 14 Nov 2024 · 22 likes Worth separating two things that post #10 runs together. Private prescription with self-payment is legal across the EU and is the common route where public…
-
When a red flag was a misunderstanding, and the retraction Replied, post #38 · Sourcing › Red flags · 21 Oct 2024 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #5 · Compounds › Secretagogues & GH axis · 21 Sep 2024 · 24 likes Worth separating two things that the opening post runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well…
-
Blind submission and why it changes minds Replied, post #62 · Sourcing › Independent verification · 15 Sep 2024 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Circumference measurements as a poor man's composition estimate Replied, post #40 · Outcomes › Body composition · 4 Aug 2024 · 0 likes post #39 answers the question as asked. The question underneath it is different. Changes during titration: measuring body composition during active titration is less…
-
Guidelines revision: what changed and why Replied, post #85 · Meta › Announcements · 27 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Cold packs, phase-change material, and what survives ten days Replied, post #103 · Sourcing › Logistics · 14 Jul 2024 · 3 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…